Excellos: Funding, Investors & Team (Oct 2026)
Excellos is a company that designs and creates cell and gene therapies to promote the progress of advanced treatments. They specialize in CAR-T, tumor-infiltrating lymphocyte therapy, and immunotherapy, offering development and clinical manufacturing services. Their goal is to help clients utilize the potential of these potent therapeutics, ultimately saving patients' lives. Excellos focuses on providing cGMP cellular products and services, as well as process development and manufacturing expertise, to scientists and doctors working with cell and gene therapies. Their mission is to expedite the development of cellular therapies and maximize their effectiveness, resulting in saved lives and improved quality of life. They aim to establish a new standard of excellence in the industry.
Excellos has raised $5.0M across 1 funding round on record, the most recent an undisclosed round of $5.0M announced in Aug 2023.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Excellos Company Profile and Key Stats
Latest funding round on record: Aug 2023.
Excellos Funding Rounds
Excellos Founders and Leadership Team
Contact details for the Excellos team: 1 of 1 has an email address on file.
Start 14-day free trial →Excellos Funding Compared to Other Biotechnology Startups
Excellos' latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Excellos in Biotechnology and San Diego
Companies Similar to Excellos
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Excellos Funding FAQs
What does Excellos do?
Excellos is a company that designs and creates cell and gene therapies to promote the progress of advanced treatments. They specialize in CAR-T, tumor-infiltrating lymphocyte therapy, and immunotherapy, offering development and clinical manufacturing services. Their goal is to help clients utilize the potential of these potent therapeutics, ultimately saving patients' lives. Excellos focuses on providing cGMP cellular products and services, as well as process development and manufacturing expertise, to scientists and doctors working with cell and gene therapies. Their mission is to expedite the development of cellular therapies and maximize their effectiveness, resulting in saved lives and improved quality of life. They aim to establish a new standard of excellence in the industry.
How much funding has Excellos raised?
Excellos has raised $5.0M across 1 round on record. The most recent is an undisclosed round of $5.0M announced in Aug 2023.
When did Excellos last raise funding?
Excellos' most recent funding round on record is an undisclosed round of $5.0M, announced in Aug 2023.
Who founded Excellos?
FundedIQ lists Robert Tressler (Founder) at Excellos.
Where is Excellos headquartered?
Excellos is based in San Diego, California, United States.
How many employees does Excellos have?
Excellos is in the 11-50 employee band.
How does Excellos' funding compare to other Biotechnology startups?
Excellos' latest round of $5.0M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Excellos Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Excellos is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.